Search alternatives:
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
small decrease » small increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
small decrease » small increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
221
-
222
Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3).
Published 2025Subjects: “…attenuates fibrosis progression…”
-
223
The trends of gene expression in the metabolism of triglycerides in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
224
After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
225
The trends of cholesterol metabolism-related gene expression in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
226
<sup>1</sup>H NMR spectra for kylo-0603.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
227
-
228
The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
229
The trends in the expression of inflammation-related genes in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
230
The Fibrosis scoring by Sirius Red staining and SHG/TPEF.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
231
Effects of Kylo-0603 on body weight, organ weight, and body fat content.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
232
The trends in the expression of fibrosis-related genes in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
233
Effects of Kylo-0603 on the expression of related genes of the MASH mouse models.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
234
-
235
<sup>13</sup>C NMR spectra for Kylo-0603.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
236
General procedure for the synthesis of A and A-c1.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
237
Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603...
Published 2025Subjects: “…attenuates fibrosis progression…”
-
238
-
239
Trends of peroxisome-related gene expression in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
240
NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day).
Published 2025Subjects: “…attenuates fibrosis progression…”